Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/13/2003US6562956 Identification and cloning of a new subfamily of sulfatases and functional embryonic techniques for characterization of such proteins
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562947 Guanosine diphosphate activation protein; for use in the of genetic disorders and cancer
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562621 Culturing and preserving mammalian cells with fish ovarian fluid; obtain ovarian fluid, generate nutrient broth, mix with ovarian fluid, culture cells in broth, remove mammalian cells, replate, continue culturing cells
05/13/2003US6562620 May be transplanted to reverse hyperglycemia
05/13/2003US6562619 Genration of preferential cell pools; prepare nutrient broth containing growth factor, inoculate with cells, propagate cells, recover cells
05/13/2003US6562618 Monoclonal antibody for use in the treatment of connective tissue, cancers, arteriosclerotic, skin and kidney disorders
05/13/2003US6562617 Library of fusion nucleic acids for use as diagnostic tools in genetic engineering
05/13/2003US6562616 Methods and devices for cell culturing and organ assist systems
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562598 Factor X deletion mutants and analogues thereof
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562596 Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562591 Cell cycle protein for use in the diagnosis and tratment of cancer and cell proliferative disorders
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562588 Sialidase and recombinant cell lines
05/13/2003US6562587 Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/13/2003US6562586 Screening compound for use a viricides; obtain virally infected sample, monitor activity and gene expression, incubate with viricide, monitor adjustment in viral gene expression and activity, adjustment in activity indicates
05/13/2003US6562580 Detection of preferential binding protein; obtain kinase protein, incubate with potential binding protein, monitor activity of kinase, adjustment in activity indicates bound protein
05/13/2003US6562563 Detection of modulator of mitochondrial permeability transition; obtain cell containing mitochondrion, incubate with modulator, exposing cell to excitation energy, detect energy transfer, compare to control
05/13/2003US6562562 Surgical process for removal of segments of liver; remove sample of tissue from animal, culture tissue, evaluate tissue
05/13/2003US6562362 Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction
05/13/2003US6562349 Otitis media vaccine
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562341 Antibodies specific for native PrPSc
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core
05/13/2003CA2086131C Anti-human ige monoclonal antibodies
05/09/2003CA2406687A1 Chimeric promoters for controlling expression in muscle cells
05/08/2003WO2003038401A2 Semiconductor nanocrystal-based cellular imaging
05/08/2003WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications
05/08/2003WO2003038090A1 Method of inducing diffrentiation of immortalized mesodermal stem cells into nervous system cells
05/08/2003WO2003038082A2 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
05/08/2003WO2003038077A1 Method of amplyfying hematopoietic stem cells
05/08/2003WO2003038076A1 Immortalized mesenchymal cells and utilization thereof
05/08/2003WO2003038075A1 Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells
05/08/2003WO2003038074A1 Method of inducing differentiation of mesoblast stem cells or es cells into nerve system cells
05/08/2003WO2003038073A2 Method for enhancing keratinocyte stem cells
05/08/2003WO2003038072A1 Generation and use of new types of dendritic cells
05/08/2003WO2003038071A1 Detection of haematopoietic stem cells and progeny and uses thereof
05/08/2003WO2003038070A1 Base material for culturing embryo stem cells and culture method
05/08/2003WO2003038069A1 Solid culture medium for micro-organisms and eukaryotic cells and the production method of same
05/08/2003WO2003038062A2 Generation of use of tc1 and tc2 cells
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038048A2 Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
05/08/2003WO2003038039A2 Novel cell-based assays for g-protein-coupled receptor-mediated activities
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003038030A1 Device with recessed tracks for forming a cellular network
05/08/2003WO2003037932A2 Human coagulation factor vii polypeptides
05/08/2003WO2003037927A1 Novel protein, its dna and use thereof
05/08/2003WO2003037918A2 Pyranosone dehydratase from phanerochaete chrysosporium
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037400A2 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037264A2 Therapeutic anti-hiv (vpr) compounds
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037247A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003025138A3 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003018040A9 Composite graft for treatment of retinal diseases
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003012084B1 Human glucose-dependent insulin-secreting cell line
05/08/2003WO2003006634A3 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
05/08/2003WO2003004617A8 Novel human proteins, polynucleotides encoding them and methods of using the same
05/08/2003WO2002098368A3 Mutant forms of cholera holotoxin as an adjuvant
05/08/2003WO2002098357A3 Microfabricated tissue as a substrate for pigment epithelium transplantation
05/08/2003WO2002091994A3 Composition and method for increasing cell density in cell cultures infected with lentivirus
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002088168A3 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
05/08/2003WO2002059279A3 Preparation of replicating kupffer cells and their use in diagnosis and therapy
05/08/2003WO2002042467A3 Aspergillus fumigatus profilin
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003US20030088890 Novel ecdysone receptors and methods for their use
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030088082 Nucleotide sequences coding polypeptide for use in veterinary medicine
05/08/2003US20030088072 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030088064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030088063 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030088060 Human ion channels
05/08/2003US20030087985 Gels for encapsulation of biological materials
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087866 Suppression of malignancy utilizing ribonucleotide reductase R1
05/08/2003US20030087859 Therapy for vision defects, central nervous system disorders; retinal pigment epithelium; genetic engineering
05/08/2003US20030087856 Antisense modulation of IL-1 receptor-associated kinase-4 expression
1 ... 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 ... 1827